Comparison of Aqueous Humor Adipokines in Glaucoma Patients and Healthy Controls
Launched by PEKING UNIVERSITY · Dec 19, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the differences in certain proteins called adipokines found in the fluid of the eye (aqueous humor) between people with primary open-angle glaucoma (POAG) and healthy individuals who have had cataract surgery. The goal is to see if these proteins could help us understand more about glaucoma and how it differs from healthy eyes.
To join the study, participants need to be at least 18 years old and either diagnosed with POAG or healthy individuals who have recently had cataract surgery. However, people with other eye diseases, recent eye surgery (except for uncomplicated cataract surgery), or certain health conditions like diabetes or mental disorders cannot participate. Participants will undergo tests to measure the levels of adipokines in their eye fluid, helping researchers gather valuable information about glaucoma. If you or someone you know fits the criteria and is interested, this could be a meaningful opportunity to contribute to our understanding of glaucoma.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or older, diagnosed with primary open-angle glaucoma (POAG) and healthy controls (who underwent cataract surgery).
- Exclusion Criteria:
- • Other Ocular Diseases: Patients with concurrent ocular diseases such as macular degeneration, retinal detachment, etc., are excluded.
- • Ocular Surgery History: individuals who have undergone intraocular or laser surgery within the past 6 months, except for uncomplicated cataract surgery.
- • History of Ocular Trauma or Inflammation
- • Systemic Diseases or Mental Disorders: Patients with systemic diseases(e.g., diabetes, rheumatoid arthritis) and those with mental disorders are excluded.
- • Pregnancy or Lactation: Females who are pregnant or lactating are excluded.
- • Presence of any retinal or optic nerve disease other than glaucoma.
About Peking University
Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Chun Zhang, Ph.D.
Principal Investigator
Peking University Third Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported